Cargando…

Connection between the Altered HDL Antioxidant and Anti-Inflammatory Properties and the Risk to Develop Alzheimer's Disease: A Narrative Review

The protein composition of high-density lipoprotein (HDL) is extremely fluid. The quantity and quality of protein constituents drive the multiple biological functions of these lipoproteins, which include the ability to contrast atherogenesis, sustained inflammation, and toxic effects of reactive spe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zimetti, Francesca, Adorni, Maria Pia, Marsillach, Judit, Marchi, Cinzia, Trentini, Alessandro, Valacchi, Giuseppe, Cervellati, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811424/ https://www.ncbi.nlm.nih.gov/pubmed/33505588 http://dx.doi.org/10.1155/2021/6695796

Ejemplares similares

HDL Proteome and Alzheimer’s Disease: Evidence of a Link
por: Marsillach, Judit, et al.
Publicado: (2020)

Paraoxonase-1 and Other HDL Accessory Proteins in Neurological Diseases
por: Marsillach, Judit, et al.
Publicado: (2021)

Lipoprotein-Associated Phospholipase A2 Activity as Potential Biomarker of Vascular Dementia
por: Zuliani, Giovanni, et al.
Publicado: (2023)

HDL metabolism and functions impacting on cell cholesterol homeostasis are specifically altered in patients with abdominal aortic aneurysm
por: Adorni, Maria Pia, et al.
Publicado: (2022)

Association between Serum Concentrations of Apolipoprotein A-I (ApoA-I) and Alzheimer’s Disease: Systematic Review and Meta-Analysis
por: Zuin, Marco, et al.
Publicado: (2021)

OxInflammation in Alzheimer’s disease
por: Cervellati, Carlo, et al.
Publicado: (2023)

BACE1: from biomarker to Alzheimer’s disease therapeutical target
por: Cervellati, Carlo, et al.
Publicado: (2021)

BACE1 role in Alzheimer's disease and other dementias: from the theory to the practice
por: Cervellati, Carlo, et al.
Publicado: (2021)

Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-Analysis
por: Zuin, Marco, et al.
Publicado: (2022)

Increased blood BACE1 activity as a potential common pathogenic factor of vascular dementia and late onset Alzheimer's disease
por: Zuliani, Giovanni, et al.
Publicado: (2020)

Testing a Combination of Markers of Systemic Redox Status as a Possible Tool for the Diagnosis of Late Onset Alzheimer's Disease
por: Zuliani, Giovanni, et al.
Publicado: (2018)

SAT-LB92 Sex Hormones Therapy Differentially Modulates HDL Function in Transgender Individuals
por: Ruscica, Massimiliano, et al.
Publicado: (2020)

HDL Cholesterol Efflux and Serum Cholesterol Loading Capacity Alterations Associate to Macrophage Cholesterol Accumulation in FH Patients with Achilles Tendon Xanthoma
por: Adorni, Maria Pia, et al.
Publicado: (2022)

PCSK9 Affects Astrocyte Cholesterol Metabolism and Reduces Neuron Cholesterol Supplying In Vitro: Potential Implications in Alzheimer’s Disease
por: Papotti, Bianca, et al.
Publicado: (2022)

Early elevation of BACE1 in dementia
por: Cervellati, Carlo, et al.
Publicado: (2021)

HDL in COVID-19 Patients: Evidence from an Italian Cross-Sectional Study
por: Papotti, Bianca, et al.
Publicado: (2021)

Proprotein Convertase Subtilisin/Kexin Type 9, Brain Cholesterol Homeostasis and Potential Implication for Alzheimer’s Disease
por: Adorni, Maria Pia, et al.
Publicado: (2019)

Cutaneous responses to environmental stressors
por: Valacchi, Giuseppe, et al.
Publicado: (2012)

OxInflammation: From Subclinical Condition to Pathological Biomarker
por: Valacchi, Giuseppe, et al.
Publicado: (2018)

TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress
por: Tisato, Veronica, et al.
Publicado: (2018)

Altered Bone Status in Rett Syndrome
por: Pecorelli, Alessandra, et al.
Publicado: (2021)

Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer’s Disease and Vascular Dementia
por: Romani, Arianna, et al.
Publicado: (2020)

Editorial: Endogenous and exogenous factors influencing the function and metabolism of lipoproteins
por: Cervellati, Carlo, et al.
Publicado: (2022)

Lactonase Activity and Lipoprotein-Phospholipase A(2) as Possible Novel Serum Biomarkers for the Differential Diagnosis of Autism Spectrum Disorders and Rett Syndrome: Results from a Pilot Study
por: Hayek, Joussef, et al.
Publicado: (2017)

Antioxidant properties of HDL
por: Soran, Handrean, et al.
Publicado: (2015)

High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives
por: Adorni, Maria Pia, et al.
Publicado: (2021)

Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late onset Alzheimer's disease (LOAD)
por: Wood, Paul L., et al.
Publicado: (2015)

Lipids at the Nexus between Cerebrovascular Disease and Vascular Dementia: The Impact of HDL-Cholesterol and Ceramides
por: Sergi, Domenico, et al.
Publicado: (2023)

Frontier on Alzheimer’s Disease
por: Cervellati, Carlo, et al.
Publicado: (2023)

Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation
por: Palumbo, Marcella, et al.
Publicado: (2022)

The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer’s Disease
por: Chernick, Dustin, et al.
Publicado: (2020)

Predictive Factors of Surgical Site Infection in Prosthetic Joint Surgery: A Prospective Study on 760 Arthroplasties
por: Maritati, Martina, et al.
Publicado: (2022)

Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies
por: Vyletelová, Veronika, et al.
Publicado: (2022)

Drug-drug interactions in polypharmacy patients: The impact of renal impairment
por: Papotti, Bianca, et al.
Publicado: (2021)

Naturally Occurring PCSK9 Inhibitors
por: Adorni, Maria Pia, et al.
Publicado: (2020)

HDL from an Alzheimer's disease perspective
por: Button, Emily B., et al.
Publicado: (2019)

Sex difference: an important issue to consider in epidemiological and clinical studies dealing with serum paraoxonase-1
por: Trentini, Alessandro, et al.
Publicado: (2019)

Increased Serum Beta-Secretase 1 Activity is an Early Marker of Alzheimer’s Disease
por: Nicsanu, Roland, et al.
Publicado: (2022)

Inflammasome involvement in CS-induced damage in HaCaT keratinocytes
por: Prieux, Roxane, et al.
Publicado: (2022)

Enhanced HDL Functionality in Small HDL Species Produced Upon Remodeling of HDL by Reconstituted HDL, CSL112: Effects on Cholesterol Efflux, Anti-Inflammatory and Antioxidative Activity
por: Didichenko, Svetlana A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_flrprd3n5lcb8e4vpsrrj3leui